BridgeMD
New treatment option for Metabolic Dysfunction-Associated Steatotic Liver Disease
Official title Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD
ClinicalTrials.gov ID: NCT07692438
What this study is testing
- What it's testing
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver condition linked to excess body fat, high blood lipids, and other metabolic problems. Taiwan green propolis is a natural health product collected by bees from plants, which has shown potential benefits for blood lipids and body fat in laboratory and animal studies.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults aged 18 to 80 years
- Diagnosis of hepatic steatosis (fatty liver) confirmed by abdominal ultrasound, PLUS at least one of the following metabolic risk factors:
- Overweight or obesity: BMI \>= 23 kg/m\^2
- Elevated waist circumference: \>= 90 cm in men or \>= 80 cm in women (South Asian and Chinese criteria)
- Dysglycemia or type 2 diabetes: prediabetes (HbA1c 5.7-6.4%, or fasting glucose 100-125 mg/dL, or OGTT 2-hour glucose 140-199 mg/dL) OR type 2...
You likely can't join if
- Known allergy to honey, propolis, multiple pollens, or alcohol
- Psychiatric disorder or cognitive impairment
- Currently pregnant or breastfeeding
- Significant endocrine abnormality, or major disease of the heart, liver (other than MASLD), or kidney
- Difficulty swallowing capsules
- Dementia, impaired consciousness, or inability to respond to questionnaires
See the full eligibility criteria
- Adults aged 18 to 80 years
- Diagnosis of hepatic steatosis (fatty liver) confirmed by abdominal ultrasound, PLUS at least one of the following metabolic risk factors:
- Overweight or obesity: BMI \>= 23 kg/m\^2
- Elevated waist circumference: \>= 90 cm in men or \>= 80 cm in women (South Asian and Chinese criteria)
- Dysglycemia or type 2 diabetes: prediabetes (HbA1c 5.7-6.4%, or fasting glucose 100-125 mg/dL, or OGTT 2-hour glucose 140-199 mg/dL) OR type 2 diabetes (HbA1c \>= 6.5%, or fasting glucose \>= 126 mg/dL, or OGTT 2-hour...
- Elevated triglycerides: \>= 150 mg/dL or currently on lipid-lowering therapy
- Low HDL-C: \<= 39 mg/dL in men or \<= 50 mg/dL in women, or currently on lipid-lowering therapy
- Elevated blood pressure: \>= 130/85 mmHg or currently on antihypertensive treatment
- Known allergy to honey, propolis, multiple pollens, or alcohol
- Psychiatric disorder or cognitive impairment
- Currently pregnant or breastfeeding
- Significant endocrine abnormality, or major disease of the heart, liver (other than MASLD), or kidney
- Difficulty swallowing capsules
- Dementia, impaired consciousness, or inability to respond to questionnaires
The study team makes the final eligibility decision.
Where it's taking place
- Dalin, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dalin, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.